首页 > 最新文献

Molecular and cellular pediatrics最新文献

英文 中文
Non-invasive pediatric cardiac imaging-current status and further perspectives. 无创儿童心脏成像的现状及进一步展望。
Q1 PEDIATRICS Pub Date : 2022-12-28 DOI: 10.1186/s40348-022-00153-z
Meinrad Beer, Björn Schönnagel, Jochen Herrmann, Steffen Klömpken, Matthias Schaal, Michael Kaestner, Christian Apitz, Horst Brunner

Background: Non-invasive cardiac imaging has a growing role in diagnosis, differential diagnosis, therapy planning, and follow-up in children and adolescents with congenital and acquired cardiac diseases. This review is based on a systematic analysis of international peer-reviewed articles and additionally presents own clinical experiences. It provides an overview of technical advances, emerging clinical applications, and the aspect of artificial intelligence.

Main body: The main imaging modalities are echocardiography, CT, and MRI. For echocardiography, strain imaging allows a novel non-invasive assessment of tissue integrity, 3D imaging rapid holistic overviews of anatomy. Fast cardiac CT imaging new techniques-especially for coronary assessment as the main clinical indication-have significantly improved spatial and temporal resolution in adjunct with a major reduction in ionizing dose. For cardiac MRI, assessment of tissue integrity even without contrast agent application by mapping sequences is a major technical breakthrough. Fetal cardiac MRI is an emerging technology, which allows structural and functional assessment of fetal hearts including even 4D flow analyses. Last but not least, artificial intelligence will play an important role for improvements of data acquisition and interpretation in the near future.

Conclusion: Non-invasive cardiac imaging plays an integral part in the workup of children with heart disease. In recent years, its main application congenital heart disease has been widened for acquired cardiac diseases.

背景:无创心脏成像在儿童和青少年先天性和获得性心脏病的诊断、鉴别诊断、治疗计划和随访中发挥着越来越重要的作用。本综述基于对国际同行评议文章的系统分析,并提出了自己的临床经验。它提供了技术进步,新兴临床应用和人工智能方面的概述。主体:主要成像方式为超声心动图、CT和MRI。对于超声心动图,应变成像允许一种新的非侵入性组织完整性评估,3D成像快速全面概述解剖结构。快速心脏CT成像新技术-特别是作为主要临床指征的冠状动脉评估-显著提高了空间和时间分辨率,同时大大降低了电离剂量。对于心脏MRI来说,通过定位序列来评估组织完整性是一项重大的技术突破,即使没有造影剂的应用。胎儿心脏MRI是一项新兴技术,可以对胎儿心脏进行结构和功能评估,甚至包括4D血流分析。最后但并非最不重要的是,在不久的将来,人工智能将在改善数据采集和解释方面发挥重要作用。结论:无创心脏显像在儿童心脏病检查中起着重要作用。近年来,其主要应用已从先天性心脏病扩大到后天性心脏病。
{"title":"Non-invasive pediatric cardiac imaging-current status and further perspectives.","authors":"Meinrad Beer,&nbsp;Björn Schönnagel,&nbsp;Jochen Herrmann,&nbsp;Steffen Klömpken,&nbsp;Matthias Schaal,&nbsp;Michael Kaestner,&nbsp;Christian Apitz,&nbsp;Horst Brunner","doi":"10.1186/s40348-022-00153-z","DOIUrl":"https://doi.org/10.1186/s40348-022-00153-z","url":null,"abstract":"<p><strong>Background: </strong>Non-invasive cardiac imaging has a growing role in diagnosis, differential diagnosis, therapy planning, and follow-up in children and adolescents with congenital and acquired cardiac diseases. This review is based on a systematic analysis of international peer-reviewed articles and additionally presents own clinical experiences. It provides an overview of technical advances, emerging clinical applications, and the aspect of artificial intelligence.</p><p><strong>Main body: </strong>The main imaging modalities are echocardiography, CT, and MRI. For echocardiography, strain imaging allows a novel non-invasive assessment of tissue integrity, 3D imaging rapid holistic overviews of anatomy. Fast cardiac CT imaging new techniques-especially for coronary assessment as the main clinical indication-have significantly improved spatial and temporal resolution in adjunct with a major reduction in ionizing dose. For cardiac MRI, assessment of tissue integrity even without contrast agent application by mapping sequences is a major technical breakthrough. Fetal cardiac MRI is an emerging technology, which allows structural and functional assessment of fetal hearts including even 4D flow analyses. Last but not least, artificial intelligence will play an important role for improvements of data acquisition and interpretation in the near future.</p><p><strong>Conclusion: </strong>Non-invasive cardiac imaging plays an integral part in the workup of children with heart disease. In recent years, its main application congenital heart disease has been widened for acquired cardiac diseases.</p>","PeriodicalId":74215,"journal":{"name":"Molecular and cellular pediatrics","volume":"9 1","pages":"21"},"PeriodicalIF":0.0,"publicationDate":"2022-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794482/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10449661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Adsorption of insulin onto neonatal infusion sets: should intravenous administration of insulin to treat hyperglycemia in preterm babies on the NICU be proceeded by priming of the intravenous system, adding of albumin, or non-priming to get to a stable insulin dose? 胰岛素在新生儿输液器上的吸附:新生儿重症监护病房早产儿静脉注射胰岛素治疗高血糖是否应该通过启动静脉系统、添加白蛋白或不启动来获得稳定的胰岛素剂量?
Q1 PEDIATRICS Pub Date : 2022-12-21 DOI: 10.1186/s40348-022-00154-y
Paola Mian, Mathieu S Bolhuis, J Marina Maurer, Margriet van Stuijvenberg

Insulin is used to treat neonatal hyperglycaemia when blood glucose concentrations are consistently high, and to treat neonatal diabetes. Within this brief report, a review of the existing literature is conducted to determine if intravenous administration of insulin should be proceeded by priming of the intravenous system, adding of albumin, or non-priming to get a stable insulin dose. Within this literature search, we focused on experimental insulin adsorption data (in vitro studies).

当血糖浓度持续偏高时,胰岛素用于治疗新生儿高血糖,并用于治疗新生儿糖尿病。在这篇简短的报告中,对现有文献进行了回顾,以确定静脉注射胰岛素是否应该通过静脉系统启动、添加白蛋白或不启动来获得稳定的胰岛素剂量。在本文献检索中,我们重点关注实验性胰岛素吸附数据(体外研究)。
{"title":"Adsorption of insulin onto neonatal infusion sets: should intravenous administration of insulin to treat hyperglycemia in preterm babies on the NICU be proceeded by priming of the intravenous system, adding of albumin, or non-priming to get to a stable insulin dose?","authors":"Paola Mian,&nbsp;Mathieu S Bolhuis,&nbsp;J Marina Maurer,&nbsp;Margriet van Stuijvenberg","doi":"10.1186/s40348-022-00154-y","DOIUrl":"https://doi.org/10.1186/s40348-022-00154-y","url":null,"abstract":"<p><p>Insulin is used to treat neonatal hyperglycaemia when blood glucose concentrations are consistently high, and to treat neonatal diabetes. Within this brief report, a review of the existing literature is conducted to determine if intravenous administration of insulin should be proceeded by priming of the intravenous system, adding of albumin, or non-priming to get a stable insulin dose. Within this literature search, we focused on experimental insulin adsorption data (in vitro studies).</p>","PeriodicalId":74215,"journal":{"name":"Molecular and cellular pediatrics","volume":"9 1","pages":"20"},"PeriodicalIF":0.0,"publicationDate":"2022-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10540041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular detection and characterization of Shigella spp. harboring extended-spectrum β-lactamase genes in children with diarrhea in northwest Iran. 伊朗西北地区儿童腹泻中携带广谱β-内酰胺酶基因的志贺氏菌的分子检测与特征分析。
Q1 PEDIATRICS Pub Date : 2022-12-08 DOI: 10.1186/s40348-022-00152-0
Sahar Sabour, Amir Teimourpour, Jafar Mohammadshahi, Hadi Peeridogaheh, Roghayeh Teimourpour, Taher Azimi, Zahra Hosseinali

Shigellosis is one of the acute bowel infections and remains a serious public health problem in resource-poor countries. The present study aimed to survey the distribution of extended-spectrum β-lactamase (ESBL)-producing Shigella strains isolated from patients with diarrhea in northwest Iran. In the present cross-sectional study, from January 2019 to December 2020, 1280 fecal samples were collected from children with diarrhea in Ardabil, Iran. Multiplex PCR assay was applied for the presence of ipaH, invC, wbgZ, rfpB, and rfc genes to detect Shigella spp., Shigella sonnei, Shigella dysenteriae, Shigella flexneri, and Shigella boydii, respectively. Phenotypic detection of ESBL-producing isolates was carried out using the Double Disc Test (DDT). The frequency of main ESBL encoding genes including blaCTX-M, blaSHV, and blaTEM was detected using multiplex PCR. The genetic similarity of S. sonnei isolates was determined using ERIC PCR. A total of 49 Shigella isolates (3.8%; 49/1280) including 42 (85.7%) S. sonnei, 5 (10.2%) S. flexneri, and 2 (4%) S. dysenteriae were identified. S. boydii was not detected in any fecal samples. ESBLs were produced by 10.2% of Shigella spp. including 3 S. sonnei, 1 S. flexneri, and 1 S. dysenteriae. The ESBL encoding genes include blaCTX-M and blaTEM found in 65.3% and 61.2% of isolates, respectively. blaSHV gene was not detected in any isolates. The ERIC-PCR profiles allowed the differentiation of 42 S. sonnei strains into 6 clusters. Our study revealed a high frequency of ESBL-encoding genes among Shigella spp. in northwest Iran. The high prevalence of S. sonnei harboring ESBL genes, in the present work, is the main challenge for dysentery treatment, and this concern justifies the need for effective and regular monitoring of antibiotic usage among patients.

志贺氏菌病是一种急性肠道感染,在资源贫乏的国家仍然是一个严重的公共卫生问题。本研究旨在调查伊朗西北部腹泻患者中产β-内酰胺酶(ESBL)的志贺氏菌的分布。在本横断面研究中,从2019年1月至2020年12月,从伊朗阿达比尔的腹泻儿童中收集了1280份粪便样本。采用多重PCR法检测ipaH、invC、wbgZ、rfpB和rfc基因的存在,分别检测志贺氏菌、sonneshigella、痢疾志贺氏菌、flexneri志贺氏菌和boydii志贺氏菌。采用双圆盘试验(DDT)对产esbl分离株进行表型检测。采用多重PCR检测ESBL主要编码基因blaCTX-M、blaSHV、blaTEM的频率。采用ERIC PCR技术对sonnei菌株进行遗传相似性分析。共有49株志贺氏菌分离株(3.8%;其中sonnei沙门氏菌42株(85.7%)、flexneri沙门氏菌5株(10.2%)、dysenteriae沙门氏菌2株(4%)。粪便标本中未检出波氏弓形虫。10.2%的志贺氏菌产生ESBLs,包括3株sonnei、1株flexneri和1株痢疾杆菌。ESBL编码基因包括blaCTX-M和blaTEM,分别在65.3%和61.2%的分离株中发现。未检出blaSHV基因。ERIC-PCR图谱可将42株sonnei菌株划分为6个聚类。我们的研究发现,在伊朗西北部的志贺氏菌中,esbl编码基因的频率很高。在目前的工作中,携带ESBL基因的sonnei的高流行率是痢疾治疗的主要挑战,这一担忧证明了对患者抗生素使用进行有效和定期监测的必要性。
{"title":"Molecular detection and characterization of Shigella spp. harboring extended-spectrum β-lactamase genes in children with diarrhea in northwest Iran.","authors":"Sahar Sabour,&nbsp;Amir Teimourpour,&nbsp;Jafar Mohammadshahi,&nbsp;Hadi Peeridogaheh,&nbsp;Roghayeh Teimourpour,&nbsp;Taher Azimi,&nbsp;Zahra Hosseinali","doi":"10.1186/s40348-022-00152-0","DOIUrl":"https://doi.org/10.1186/s40348-022-00152-0","url":null,"abstract":"<p><p>Shigellosis is one of the acute bowel infections and remains a serious public health problem in resource-poor countries. The present study aimed to survey the distribution of extended-spectrum β-lactamase (ESBL)-producing Shigella strains isolated from patients with diarrhea in northwest Iran. In the present cross-sectional study, from January 2019 to December 2020, 1280 fecal samples were collected from children with diarrhea in Ardabil, Iran. Multiplex PCR assay was applied for the presence of ipaH, invC, wbgZ, rfpB, and rfc genes to detect Shigella spp., Shigella sonnei, Shigella dysenteriae, Shigella flexneri, and Shigella boydii, respectively. Phenotypic detection of ESBL-producing isolates was carried out using the Double Disc Test (DDT). The frequency of main ESBL encoding genes including bla<sub>CTX-M</sub>, bla<sub>SHV</sub>, and bla<sub>TEM</sub> was detected using multiplex PCR. The genetic similarity of S. sonnei isolates was determined using ERIC PCR. A total of 49 Shigella isolates (3.8%; 49/1280) including 42 (85.7%) S. sonnei, 5 (10.2%) S. flexneri, and 2 (4%) S. dysenteriae were identified. S. boydii was not detected in any fecal samples. ESBLs were produced by 10.2% of Shigella spp. including 3 S. sonnei, 1 S. flexneri, and 1 S. dysenteriae. The ESBL encoding genes include bla<sub>CTX-M</sub> and bla<sub>TEM</sub> found in 65.3% and 61.2% of isolates, respectively. bla<sub>SHV</sub> gene was not detected in any isolates. The ERIC-PCR profiles allowed the differentiation of 42 S. sonnei strains into 6 clusters. Our study revealed a high frequency of ESBL-encoding genes among Shigella spp. in northwest Iran. The high prevalence of S. sonnei harboring ESBL genes, in the present work, is the main challenge for dysentery treatment, and this concern justifies the need for effective and regular monitoring of antibiotic usage among patients.</p>","PeriodicalId":74215,"journal":{"name":"Molecular and cellular pediatrics","volume":"9 1","pages":"19"},"PeriodicalIF":0.0,"publicationDate":"2022-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732178/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10537958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subcutaneous fat necrosis in newborns: a systematic literature review of case reports and model of pathophysiology. 新生儿皮下脂肪坏死:病例报告和病理生理学模型的系统文献综述。
Q1 PEDIATRICS Pub Date : 2022-11-24 DOI: 10.1186/s40348-022-00151-1
Leonie Frank, Stephanie Brandt, Martin Wabitsch

Background: Subcutaneous fat necrosis of the newborn (SCFN) is a rare disease occurring in the first days of life. Characteristically, the infants show hard nodules in subcutaneous tissue, purple or erythematous in color and appear on the upper back, cheeks, buttocks and limbs. In most cases, SCFN is a self-limiting disease, as the nodules disappear in up to 6 months. A severe complication associated with SCFN is hypercalcaemia. Pathophysiological mechanisms causing SCFN or associated hypercalcaemia are not fully understood yet.

Methods: A systematic literature research including the six biggest databases for medical research has been used to identify all published case reports of SCFN. N = 206 publications has been identified containing n = 320 case reports. All cases have been classified into four subgroups (depending on reported serum-calcium-level): hypercalcaemia, normocalcaemia, hypocalcaemia or no information given. Reported maternal factors, birth characteristics, details about SCFN, diagnostics, therapy and long-term observations have been extracted from publications.

Results: This is the first systematic literature research that summed up all published cases of SCFN from 1948 up to 2018. Information about serum calcium level was given in 64.3% of the cases. From those, the majority showed hypercalcaemia (70.5%) (normocalcaemia 25.1%, hypocalcemia 4.3%). 89.3% of newborns with hypercalcaemia showed suppressed levels of the parathormone. Maternal gestational diabetes, maternal hypertensive diseases during pregnancy, macrosomia (> 4000g), asphyxia and therapeutic hypothermia are risk factors for SCFN. Histological findings showed a granulomatous inflammation in 98% of cases.

Conclusion: We identified that maternal, birth characteristics and therapeutic measures are probably risk factors for SCFN. These risk factors should be taken into account within the care of neonates.

背景:新生儿皮下脂肪坏死(SCFN)是一种发生在生命最初几天的罕见疾病。婴儿的特征是皮下组织有硬结节,颜色为紫色或红斑,出现在上背部、脸颊、臀部和四肢。在大多数病例中,SCFN是一种自限性疾病,结节会在6个月内消失。与SCFN相关的严重并发症是高钙血症。引起SCFN或相关高钙血症的病理生理机制尚不完全清楚。方法:系统的文献研究,包括六个最大的医学研究数据库,识别所有已发表的SCFN病例报告。已确定N = 206份出版物,其中包含N = 320例病例报告。所有病例被分为四个亚组(取决于报告的血钙水平):高钙血症、正常钙血症、低钙血症或无资料。已报道的母体因素、出生特征、SCFN的细节、诊断、治疗和长期观察均摘自出版物。结果:这是第一个系统的文献研究,总结了1948 - 2018年所有已发表的SCFN病例。64.3%的病例提供了血钙水平信息。其中,大多数表现为高钙血症(70.5%)(正常钙血症25.1%,低钙血症4.3%)。89.3%的新生儿高钙血症表现出甲状旁激素水平的抑制。妊娠期孕妇糖尿病、妊娠期孕妇高血压疾病、巨大儿(> 4000g)、窒息和治疗性低温是SCFN的危险因素。组织学结果显示98%的病例为肉芽肿性炎症。结论:我们发现母亲、出生特征和治疗措施可能是SCFN的危险因素。在新生儿护理中应考虑到这些风险因素。
{"title":"Subcutaneous fat necrosis in newborns: a systematic literature review of case reports and model of pathophysiology.","authors":"Leonie Frank,&nbsp;Stephanie Brandt,&nbsp;Martin Wabitsch","doi":"10.1186/s40348-022-00151-1","DOIUrl":"https://doi.org/10.1186/s40348-022-00151-1","url":null,"abstract":"<p><strong>Background: </strong>Subcutaneous fat necrosis of the newborn (SCFN) is a rare disease occurring in the first days of life. Characteristically, the infants show hard nodules in subcutaneous tissue, purple or erythematous in color and appear on the upper back, cheeks, buttocks and limbs. In most cases, SCFN is a self-limiting disease, as the nodules disappear in up to 6 months. A severe complication associated with SCFN is hypercalcaemia. Pathophysiological mechanisms causing SCFN or associated hypercalcaemia are not fully understood yet.</p><p><strong>Methods: </strong>A systematic literature research including the six biggest databases for medical research has been used to identify all published case reports of SCFN. N = 206 publications has been identified containing n = 320 case reports. All cases have been classified into four subgroups (depending on reported serum-calcium-level): hypercalcaemia, normocalcaemia, hypocalcaemia or no information given. Reported maternal factors, birth characteristics, details about SCFN, diagnostics, therapy and long-term observations have been extracted from publications.</p><p><strong>Results: </strong>This is the first systematic literature research that summed up all published cases of SCFN from 1948 up to 2018. Information about serum calcium level was given in 64.3% of the cases. From those, the majority showed hypercalcaemia (70.5%) (normocalcaemia 25.1%, hypocalcemia 4.3%). 89.3% of newborns with hypercalcaemia showed suppressed levels of the parathormone. Maternal gestational diabetes, maternal hypertensive diseases during pregnancy, macrosomia (> 4000g), asphyxia and therapeutic hypothermia are risk factors for SCFN. Histological findings showed a granulomatous inflammation in 98% of cases.</p><p><strong>Conclusion: </strong>We identified that maternal, birth characteristics and therapeutic measures are probably risk factors for SCFN. These risk factors should be taken into account within the care of neonates.</p>","PeriodicalId":74215,"journal":{"name":"Molecular and cellular pediatrics","volume":"9 1","pages":"18"},"PeriodicalIF":0.0,"publicationDate":"2022-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700527/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10623827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Ultrasound elastography in children — nice to have for scientific studies or arrived in clinical routine? 儿童超声弹性成像-用于科学研究还是临床常规?
Q1 PEDIATRICS Pub Date : 2022-06-06 DOI: 10.1186/s40348-022-00143-1
H. Mentzel, K. Glutig, Stephanie Gräger, Paul C. Krüger, M. Waginger
{"title":"Ultrasound elastography in children — nice to have for scientific studies or arrived in clinical routine?","authors":"H. Mentzel, K. Glutig, Stephanie Gräger, Paul C. Krüger, M. Waginger","doi":"10.1186/s40348-022-00143-1","DOIUrl":"https://doi.org/10.1186/s40348-022-00143-1","url":null,"abstract":"","PeriodicalId":74215,"journal":{"name":"Molecular and cellular pediatrics","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47122683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
How peritoneal dialysis transforms the peritoneum and vasculature in children with chronic kidney disease—what can we learn for future treatment? 腹膜透析如何改变儿童慢性肾脏疾病的腹膜和血管系统——我们对未来的治疗有什么了解?
Q1 PEDIATRICS Pub Date : 2022-05-05 DOI: 10.1186/s40348-022-00141-3
M. Bartosova, S. Zarogiannis, C. Schmitt, Klaus Gema Aysun K. Rainer Salim Rimante Dorota Sahar Gü Arbeiter Ariceta Bayazit Büscher Caliskan Cerkausk, K. Arbeiter, G. Ariceta, A. Bayazıt, R. Büscher, S. Çalışkan, R. Čerkauskienė, D. Drożdż, S. Fathallah-Shaykh, G. Klaus, R. Krmar, J. Oh, V. Peters, U. Querfeld, B. Ranchin, P. Sallay, B. Schaefer, C. Taylan, S. Testa, J. Vandewalle, E. Verrina, K. Vondrák, B. Warady, Y. Yap, A. Zaloszyc
{"title":"How peritoneal dialysis transforms the peritoneum and vasculature in children with chronic kidney disease—what can we learn for future treatment?","authors":"M. Bartosova, S. Zarogiannis, C. Schmitt, Klaus Gema Aysun K. Rainer Salim Rimante Dorota Sahar Gü Arbeiter Ariceta Bayazit Büscher Caliskan Cerkausk, K. Arbeiter, G. Ariceta, A. Bayazıt, R. Büscher, S. Çalışkan, R. Čerkauskienė, D. Drożdż, S. Fathallah-Shaykh, G. Klaus, R. Krmar, J. Oh, V. Peters, U. Querfeld, B. Ranchin, P. Sallay, B. Schaefer, C. Taylan, S. Testa, J. Vandewalle, E. Verrina, K. Vondrák, B. Warady, Y. Yap, A. Zaloszyc","doi":"10.1186/s40348-022-00141-3","DOIUrl":"https://doi.org/10.1186/s40348-022-00141-3","url":null,"abstract":"","PeriodicalId":74215,"journal":{"name":"Molecular and cellular pediatrics","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41895546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
When inflammation meets lung development—an update on the pathogenesis of bronchopulmonary dysplasia 当炎症与肺发育相结合——支气管肺发育不良发病机制的最新进展
Q1 PEDIATRICS Pub Date : 2022-04-20 DOI: 10.1186/s40348-022-00137-z
Lena Holzfurtner, T. Shahzad, Ying Dong, Lisa Rekers, Ariane Selting, B. Staude, Tina Lauer, A. Schmidt, S. Rivetti, K. Zimmer, Judith Behnke, S. Bellusci, H. Ehrhardt
{"title":"When inflammation meets lung development—an update on the pathogenesis of bronchopulmonary dysplasia","authors":"Lena Holzfurtner, T. Shahzad, Ying Dong, Lisa Rekers, Ariane Selting, B. Staude, Tina Lauer, A. Schmidt, S. Rivetti, K. Zimmer, Judith Behnke, S. Bellusci, H. Ehrhardt","doi":"10.1186/s40348-022-00137-z","DOIUrl":"https://doi.org/10.1186/s40348-022-00137-z","url":null,"abstract":"","PeriodicalId":74215,"journal":{"name":"Molecular and cellular pediatrics","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43276843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
Uni-ventricular palliation vs. bi-ventricular repair: differential inflammatory response 单心室缓解vs双心室修复:不同的炎症反应
Q1 PEDIATRICS Pub Date : 2022-03-20 DOI: 10.1186/s40348-022-00138-y
M. Sigler, H. Rouatbi, J. Vázquez-Jiménez, M. Seghaye
{"title":"Uni-ventricular palliation vs. bi-ventricular repair: differential inflammatory response","authors":"M. Sigler, H. Rouatbi, J. Vázquez-Jiménez, M. Seghaye","doi":"10.1186/s40348-022-00138-y","DOIUrl":"https://doi.org/10.1186/s40348-022-00138-y","url":null,"abstract":"","PeriodicalId":74215,"journal":{"name":"Molecular and cellular pediatrics","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44725631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Precision medicine in pediatric oncology 更正:儿科肿瘤学中的精准医学
Q1 PEDIATRICS Pub Date : 2022-03-10 DOI: 10.1186/s40348-022-00140-4
S. Burdach, M. Westhoff, M. Steinhauser, K. Debatin
{"title":"Correction to: Precision medicine in pediatric oncology","authors":"S. Burdach, M. Westhoff, M. Steinhauser, K. Debatin","doi":"10.1186/s40348-022-00140-4","DOIUrl":"https://doi.org/10.1186/s40348-022-00140-4","url":null,"abstract":"","PeriodicalId":74215,"journal":{"name":"Molecular and cellular pediatrics","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48599681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DMBT1 is upregulated in cystic fibrosis, affects ciliary motility, and is reduced by acetylcysteine DMBT1在囊性纤维化中上调,影响纤毛运动,并被乙酰半胱氨酸降低
Q1 PEDIATRICS Pub Date : 2022-03-05 DOI: 10.1186/s40348-022-00136-0
Alexander Kiefer, Erika Plattner, R. Ruppel, C. Weiss, Z. Zhou-Suckow, M. Mall, M. Renner, H. Müller
{"title":"DMBT1 is upregulated in cystic fibrosis, affects ciliary motility, and is reduced by acetylcysteine","authors":"Alexander Kiefer, Erika Plattner, R. Ruppel, C. Weiss, Z. Zhou-Suckow, M. Mall, M. Renner, H. Müller","doi":"10.1186/s40348-022-00136-0","DOIUrl":"https://doi.org/10.1186/s40348-022-00136-0","url":null,"abstract":"","PeriodicalId":74215,"journal":{"name":"Molecular and cellular pediatrics","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49654119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Molecular and cellular pediatrics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1